Technology and Software lead the charge with several stocks (ARM, SNAP, ZM, ABNB, NET) recently rated strong buy by analysts on Wednesday and Tuesday. Biotech also sees significant upgrades, including INCY and KPTI. Average target upsides suggest continued momentum in these growth sectors. However, notable downgrades in Chemicals (CF, DQ) and Logistics (ODFL) signal caution for investors in those industries.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.